Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,445
Closed -$800K 106
2025
Q4
$800K Sell
2,445
-876
-26% -$278K 0.04% 537
2025
Q3
$937K Buy
+3,321
New +$963K 0.06% 455
2025
Q2
Sell
-42
Closed -$13.1K 2031
2025
Q1
$13.1K Sell
42
-1,951
-98% -$576K ﹤0.01% 1769
2024
Q4
$519K Buy
1,993
+74
+4% +$22K 0.07% 459
2024
Q3
$618K Buy
1,919
+1,804
+1,569% +$590K 0.06% 569
2024
Q2
$35.9K Sell
115
-3,125
-96% -$918K ﹤0.01% 1188
2024
Q1
$921K Buy
3,240
+818
+34% +$239K 0.16% 212
2023
Q4
$698K Buy
+2,422
New +$660K 0.15% 235

Other funds holding AMGN

AlphaQuest's AMGN Position: Q1 2026 in Review

AlphaQuest sold out of Amgen (AMGN) in Q1 2026, closing a stake of 2,445 shares — an estimated $800K sold.

AlphaQuest first reported a position in AMGN in Q4 2023 and held it in 8 quarters. The position peaked at $937K in Q3 2025. 3,148 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AlphaQuest reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 2,445 Amgen shares in Q1 2026, an estimated $800K.
  • AlphaQuest first reported a position in Amgen in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Amgen position peaked at $937K in Q3 2025.
  • 3,148 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.